Agriculture company, Monsanto, has spent years in court and seemingly endless money to fight dairies who were labeling their milk rBGH-free. The compound - genetically engineered Recombinant bovine growth hormone (hence rBGH) has had controversy swirling around it for some time. Apparently the company is now fed up and facing a growing backlash against rBGH, which once conquered the U.S. dairy industry. Monsanto is selling the rights to produce Posilac, its name for the the product.
Apparently Posilac had become a marginal part of Monsanto’s profit growth - which derives mainly from its dominance of the genetically modified corn, soy, and cotton seed markets – so they’re willing to let it go. And that’s probably good news for small farms fighting big Monsanto litigation.
Whatever company buys it probably won’t have Monsanto’s supply of money – or the company’s litigious desire to try to prevent dairies from labeling their products rBGH-free. The announcement marks a victory for consumers’ right to know what’s in their food.
Add a Comment